MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202647122995 A) filed by Aurigene Oncology Limited on October 14, 2026, for Fused Bicyclic Compounds As Smarca2 And/Or Smarca4 Degraders.
Inventors include Abbineni, Chandrasekhar; Samajdar, Susanta; and Kuila, Bilash.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention provides fused bicyclic compounds of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of disease or disorder dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides pharmaceutic...